ENTRADA THERAPEUTICS, INC. (TRDA) Shareholders’ equity 2023–2025
ENTRADA THERAPEUTICS, INC. (TRDA) shareholders’ equity at each fiscal year-end, per SEC filings.
$306.1MFY2025 · since FY2023: $242.4M → $306.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $306.1M | -28.6% |
| FY2024 | $428.7M | +76.9% |
| FY2023 | $242.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice